Camellia Oil-Enriched Diet Attenuates Oxidative Stress and Inflammatory Markers in Hypercholesterolemic Subjects

Journal of Medicinal Food

Volumn 19, Issue 9, 2016, Pages 895-898

  Bumrungpert, Akkarach ^a   Pavadhgul, Patcharanee ^a   Kalpravidh, Ruchaneekorn W ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Camellia oil; Hypercholesterolemia; Inflammation; Monounsaturated fatty acids; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CAMELLIA OIL; EDIBLE OIL; GLUTATHIONE; HIGH SENSITIVITY C REACTIVE PROTEIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; SOYBEAN OIL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; VEGETABLE OIL;

ADULT; ARTICLE; CAMELLIA OLEIFERA; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; MEAL; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SINGLE BLIND PROCEDURE; BLOOD; CAMELLIA; CHEMISTRY; DIET; DRUG EFFECT; LIPID PEROXIDATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYTOTHERAPY; PLANT SEED;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BIOMARKERS; C-REACTIVE PROTEIN; CAMELLIA; DIET; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT OILS; SEEDS; SINGLE-BLIND METHOD;

EID: 84988358259     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2016.3659     Document Type: Article

References (21)

1. Wong ND: Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol 2014;11:276-289.
2. Duarte MM, Rocha JB, Moresco RN, et al.: Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 2009;42: 666-671.
3. Ma J, Ye H, Rui Y, Chen G, Zhang N: Fatty acid composition of Camellia oleifera oil. J Verbrauch Lebensm 2011;6:9-12.
4. Lee CP, Yen GC: Antioxidant activity and bioactive compounds of tea seed (Camellia oleifera Abel.) oil. J Agric Food Chem 2006;54:779-784.
5. Fazel M, Sahari MA, Barzegar M: Determination of main tea seed oil antioxidants and their effects on common Kilka Oil. Int Food Res J 2008;15:209-217.
6. Lee CP, Shih PH, Hsu CL, Yen GC: Hepatoprotection of tea seed oil (Camellia oleifera Abel.) against CCl4-induced oxidative damage in rats. Food Chem Toxicol 2007;45:888-895.
7. Yang RL, Shi YH, Hao G, Li W, Le GW: Increasing oxidative stress with progressive hyperlipidemia in human: Relation between malondialdehyde and atherogenic index. J Clin Biochem Nutr 2008;43:154-158.
8. Kalpravidh RW, Siritanaratkul N, Insain P, et al.: Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/ Hb E patients treated with curcuminoids. Clin Biochem 2010;43:424-429.
9. Phuntuwate W, Suthisisang C, Koanantakul B, Chaloeiphap P, Mackness B, Mackness M: Effect of fenofibrate therapy on paraoxonase1 status in patients with low HDL-C levels. Atherosclerosis 2008;196:122-128.
10. Horiuchi Y, Hirayama S, Soda S, et al.: Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels. J Atheroscler Thromb 2010;17:722-729.
11. Ascer E, Bertolami MC, Venturinelli ML, et al.: Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients. Atherosclerosis 2004;177:161-166.
12. Pearson TA, Mensah GA, Alexander RW, et al.: Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 2003;107:499-511.
13. Teng KT, Chang CY, Chang LF, Nesaretnam K: Modulation of obesity-induced inflammation by dietary fats: Mechanisms and clinical evidence. Nutr J 2014;13: 1-15.
14. Devaraj S, Tang R, Adams-Huet B, et al.: Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am J Clin Nutr 2007;86:1392-1398.
15. Wallenfeldt K, Fagerberg B, Wikstrand J, Hulthe J: Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Intern Med 2004;256:413-420.
16. Fuller CJ, Jialal I: Effects of antioxidants and fatty acids in lowdensity-lipoprotein oxidation.AmJClinNutr 1994;60:1010S-1013S.
17. Moreno JA, López-Miranda J, Pérez-Mart?nez P, et al.: A monounsaturated fatty acid-rich diet reduces macrophage uptake of plasma oxidised low-density lipoprotein in healthy young men. Br J Nutr 2008;100:569-575.
18. Galland L: Diet and inflammation. Nutr Clin Pract 2010;25: 634-640.
19. Jenkins DJ, Chiavaroli L, Wong JM, et al.: Adding monounsaturated fatty acids to a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. CMAJ 2010;182:1961-1967.
20. Morrison M, van der Heijden R, Heeringa P, et al.: Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFjB in vivo. Atherosclerosis 2014;233:149-156.
21. Chiang HM, Chang H, Yao PW, et al.: Sesamin reduces acute hepatic injury induced by lead coupled with lipopolysaccharide. J Chin Med Assoc 2014;77:227-233.